Over 15 years working on Parkinson's disease. Founding CEO at NeuroInitiative since 2014 where she laid out a vision for applying advanced computational drug discovery methods which led to creation of Vincere Biosciences where she is also CEO. Previously she worked with Matt Farrer at Mayo clinic to characterize genetic models of Parkinson's disease and was part of the team that discovered a new pathogenic mutation in VPS35. Her PhD work implemented cutting edge laser capture, microarray, and in vivo siRNA techniques to identify protective genomic changes in Parkinson’s models. Recipient of JBJ’s 40 under 40 award, winner of One Spark’s science award, and supporter of science on the TEDx and March for Science stages.

PhD in Neuroscience from Michigan State University, postdoctoral work at Mayo Clinic.